Rising Life-Style Diseases To Augment Metabolic Testing Market Growth

Metabolic Testing Market

Metabolic Testing Market by Product Type (Body Composition Analyzers, Cardiopulmonary Exercise Testing (CPET) Systems, ECG Systems, Metabolic Carts, Others), Application (Critical Care, Lifestyle Diseases), End User (Hospitals and, Clinics, Sports Training Centers, Others), Geography (North America, Europe, Asia-Pacific, and Rest of the World) Size, Share, Outlook, and Opportunity Analysis, 2023-2030.

The global Metabolic Testing Market is estimated to be valued at reach US$ 440.7 million in 2023 and is expected to exhibit a CAGR of 7.5 % over the forecast period, as highlighted in a new report published by Coherent Market Insights.

Market Overview:

Metabolic testing includes a number of various tests. Each test offers data regarding a key element of the metabolism. These elements comprises the Resting metabolic rate. Testing this feature of the metabolism offers data regarding the approximated count of calories one burns when the body is at rest as one is not exercising or moving.

Global Metabolic Testing Market Size Was Valued At US$ 596.3 Million In 2022 And Is Expected To Witness A CAGR Of 7.6 % Over The Forecast Period (2022 – 2030).

Competitive Landscape:

Key players involved in the growth of global Metabolic Testing Market are KORR Medical Technologies, Inc, MGC Diagnostics Corporation, General Electric Company (GE Healthcare), COSMED Srl, CareFusion Corporation, AEI Technologies, Inc, CORTEX Biophysik GmbH, Geratherm Medical AG, OSI Systems, Inc, and Parvo Medics.

Market Key Drivers:

Rising prevalence of lifestyle diseases such as heart diseases, high- cholesterol, diabetes, and obesity across the globe is expected to boost the global metabolic testing market. For instance, as per the World Obesity Atlas 2022, it is predicted that 1 in 5 women and 1 in 7 men are known to suffer from obesity, equating to above 1 billion people across the globe.

Rising cases of hypertension is projected to propel the growth of global metabolic testing market. For instance as per WHO, around 1.13 billion people across the globe suffer from hypertension.

Covid-19 Impact Analysis:

The COVID-19 pandemic considerably affected the growth of global Metabolic Testing Market owing to the rising sedentary lifestyles and less physical activities because of the lockdown. For example, as per MedRxiv journal’s article, the COVID-19 epidemic enlarged sedentary lifestyles and unhygienic dietary habits. Consequently the rise in metabolic disorders caused by unhygienic dietary habits, the necessity for metabolic testing rose in the pandemic. 

Key Takeaways:

The global Metabolic Testing Market is anticipated to exhibit a CAGR of 7.5 % during the forecast period due to rising approvals and product launches. For instance, In December 2022, Rutgers University and HeartSciences announced a launch of multi-year partnership to create AI-based ECG algorithms to enhance cardiovascular disorders exposure and increase the medical value of an ECG for low-cost identification of cardiovascular disorders. 

Among regions, North America, Europe, and Asia Pacific are expected to witness robust growth in the global Metabolic Testing Market due to rising mergers and acquisitions, rising chronic diseases, rising lifestyle diseases, increasing launches and product approvals and rising collaborations and partnerships. For instance, as per the CDC January 2023, over half of the adults in U.S. i.e., 47%, or 116 million have high blood pressure, above 130 MgH.